Incidence and Risk Factors of Nasal Carriage of Staphylococcus aureus in HIV-Infected Individuals in Comparison to HIV-Uninfected Individuals: A Case-Control Study

Journal of the International Association of Providers of AIDS Care

Volumn 15, Issue 2, 2016, Pages 141-147

  Kotpal, Ruchi ^a   Krishna Prakash, S ^b   Bhalla, Preena ^b   Dewan, Richa ^c   Kaur, Ravinder ^b  

^a Microbiology at Super Religare Laboratories   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

^c LOK NAYAK HOSPITAL   (India)

Author keywords

HIV infected; HIV uninfected; methicillin resistant Staphylococcus aureus; nasal carriage; Staphylococcus aureus

Indexed keywords

PSEUDOMONIC ACID; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORBIDITY; NOSE SMEAR; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURGICAL TECHNIQUE; TEACHING HOSPITAL; CASE CONTROL STUDY; COMPLICATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NOSE; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; NOSE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84962615054     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957414554005     Document Type: Article

References (18)

1. Chacko J, Kuruvila M, Bhat GK,. Factors affecting the nasal carriage of Methicillin resistant Staphylococcus aureus in Human Immunodeficiency Virus infected patients. Indian J Med Microbiol. 2009; 27 (2): 146-148.
2. Goetz AM, Squier C, Wagener MM, Muder RR,. Nosocomial infections in the human immunodeficiency virus-infected patient: a two-year survey. Am J Infect Control. 1994; 22 (6): 334-339.
3. Nguyen MH, Kauffman CA, Goodman RP, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med. 1999; 130 (3): 221-225.
4. Wenzel RP, Nettleman MD, Jones RN, Pfalller MA,. Methicillin-resistant Staphylococcus aureus: Implications for the 1990s and effective control measures. Am J Med. 1991; 91 (3B): 221S-227S.
5. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD,. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1992; 11 (11): 985-989.
6. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29 (11): 996-1011.
7. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA. 1999; 282 (12): 1123-1125.
8. Clinical Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing. National Committee for Clinical Laboratory Standards Twentieth Informational Supplement M100-S20. 2010; 30 (1): 101.
9. Blair JE, Williams REO,. Phage typing of staphylococci. Bull World Health Organ. 1961; 24 (6): 771-784.
10. Stokes EJ, Ridgway GL, Wren MWD., Clinical Microbiology. 7th edn. London: Edward Arnold A division of Hodder & Stoughton; 1993 (17).
11. Villacian JS, Barkham T, Earnest A, Paton NI,. Prevalence of and risk factors for nasal colonization with Staphylococcus aureus among human immunodeficiency virus positive outpatients in Signapore. Infect Control Hosp Epidemiol. 2004; 25 (5): 438-440.
12. McDonald LC, Lauderdale TL, Lo HJ, Tsai JJ, Hung CC,. Colonization of HIV infected outpatients in Taiwan with Methicillin resistant and Methicillin susceptible Staphylococcus aureus. Int J STD AIDS. 2003; 14 (7): 473-477.
13. Cenizal MJ, Hardy RD, Anderson M, Katz K, Skiest DJ,. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients. J Acquir Immune Defic Syndr. 2008; 48 (5): 567-571.
14. Ammerlaan HSM, Kluytmans JW, Wertheim HF, Nouwen JL, Bonten MJM,. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis. 2009; 48 (7): 922-930.
15. Laupland KB, Conly JM,. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis. 2003; 37 (7): 933-938.
16. Gilbert DN, Moellering R, Sande M,. The Sanford Guide to Antimicrobial Therapy. 32nd ed. Hyde Park, VT: Antimicrobial Therapy Inc., 2002.
17. Nishijima S, Kurokawa I,. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections. Int J Antimicrob Agents. 2002; 19 (3): 241-243.
18. Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis. 1993; 17 (3): 466-474.